Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.

Lopez FL, Agarwal SK, Maclehose RF, Soliman EZ, Sharrett AR, Huxley RR, Konety S, Ballantyne CM, Alonso A.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):155-62. doi: 10.1161/CIRCEP.111.966804. Epub 2012 Jan 6.

PMID:
22227953
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Oct 11;11:125. doi: 10.1186/1475-2840-11-125. Review.

PMID:
23057687
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Huxley RR, Filion KB, Konety S, Alonso A.

Am J Cardiol. 2011 Jul 1;108(1):56-62. doi: 10.1016/j.amjcard.2011.03.004. Epub 2011 Apr 27. Review.

PMID:
21529739
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk